Is PETS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PETS. It does not provide personalized investment advice.

PETS (PetMed Express, Inc.) Stock Analysis - Financials

PetMed Express, Inc. (PETS) is a publicly traded Healthcare sector company. As of August 19, 2026, PETS trades at $1.80 with a market cap of $37.94M and a P/E ratio of -1.28. PETS moved +2.57% today. Year to date, PETS is -43.75%; over the trailing twelve months it is -40.98%. Its 52-week range spans $1.57 to $5.58. Rallies surfaces PETS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PETS's key financials?

PETS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PETS recently traded at $1.80. Market cap is $37.94M. P/E ratio is -1.28. Revenue is $168.86M.

PETS Key Metrics

Key financial metrics for PETS
Metric	Value
Price	$1.80
Market Cap	$37.94M
P/E Ratio	-1.28
EPS	$-1.38
Dividend Yield	0.30%
52-Week High	$5.58
52-Week Low	$1.57
Volume	86.34K
Avg Volume	0
Revenue (TTM)	$168.86M
Net Income	$-29.28M
Gross Margin	27.92%

PETS Analyst Consensus

PETS analyst coverage data. Average price target: $0.00.

Common questions about PETS

What are PETS's key financials?: PETS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PETS recently traded at $1.80. Market cap is $37.94M. P/E ratio is -1.28. Revenue is $168.86M.
Is PETS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PETS. It does not provide personalized investment advice.